Atlas Trials

Phase IIa L-serine Trial for eAD

Clinical trial NCT03062449 · TERMINATED

Trial details

NCT number
NCT03062449
Sponsor
Aleksandra Stark
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2017-03-01
Primary completion
2021-07-20
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.